Phase 0 1 trial
Phase 0
NCT04803123 Jun 2021 → Apr 2023 adult acute lymphoblastic leukemia Dorothy Sipkins, MD, PhD
Terminated
No outcome recorded
Phase 1 31 trials
Phase 1
NCT04933617 Mar 2022 → Nov 2023 Burkitt lymphoma , T-cell/histiocyte rich large B cell lymphoma , diffuse large B-cell lymphoma germinal center B-cell type , high grade B-cell lymphoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT05010096 Mar 2022 bone cancer , high grade malignant neoplasm , metastatic malignant neoplasm M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1
NCT04895579 May 2021 → Nov 2025 non-small cell lung carcinoma Zhonglin Hao
Completed
No outcome recorded
Phase 1
NCT04462471 Jun 2020 → Sep 2023 thyroid gland follicular carcinoma , thyroid gland papillary carcinoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT03939897 Jun 2020 → Jun 2023 overdue female breast carcinoma , hormone receptor-positive breast cancer National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT04431635 Jun 2020 → Nov 2023 indolent B-cell non-Hodgkin lymphoma University of Michigan Rogel Cancer Center
Terminated
No outcome recorded
Phase 1
NCT03878524 Apr → Dec 2020 acute myeloid leukemia , atypical chronic myeloid leukemia, BCR-ABL1 negative , blast phase chronic myelogenous leukemia, BCR-ABL1 positive , castration-resistant prostate carcinoma +14 OHSU Knight Cancer Institute
Terminated
No outcome recorded
Phase 1
NCT04156828 Mar 2020 → Apr 2022 diffuse large B-cell lymphoma , follicular lymphoma University of Washington
Terminated
No outcome recorded
Phase 1
NCT04233697 Feb 2020 → Jul 2022 T-cell non-Hodgkin lymphoma Columbia University
Withdrawn
No outcome recorded
Phase 1
NCT03842228 Nov 2019 → Jul 2024 overdue metastatic malignant neoplasm National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT04042051 Nov 2019 → Nov 2020 HER2 positive breast carcinoma Cancer Trials Ireland
Terminated
No outcome recorded
Phase 1
NCT03886649 Nov 2019 → May 2021 non-Hodgkin lymphoma Swiss Cancer Institute
Terminated
No outcome recorded
Phase 1
NCT03586661 Apr 2019 → Jun 2026 BRCA1-related cancer predisposition , BRCA2-related cancer predisposition , endometrium adenocarcinoma , fallopian tube carcinoma +2 M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1
NCT03884998 Feb 2019 → Nov 2026 expected B-cell chronic lymphocytic leukemia , Richter transformation , diffuse large B-cell lymphoma , follicular lymphoma +2 City of Hope Medical Center
Active not recruiting
No outcome recorded
Phase 1
NCT03735628 Oct 2018 → Oct 2022 head and neck squamous cell carcinoma , hepatocellular carcinoma , non-small cell lung carcinoma Bayer
Completed
No outcome recorded
Phase 1
NCT03655301 Sep → Nov 2018 —
Bayer
Completed
No outcome recorded
Phase 1
NCT03502733 Aug 2018 → Jul 2026 overdue lymphoma , metastatic malignant neoplasm National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1
NCT03517956 Jul 2018 → Feb 2021 —
Bayer
Completed
No outcome recorded
Phase 1
NCT03498430 Apr 2018 → Aug 2019 non-Hodgkin lymphoma Bayer
Completed
No outcome recorded
Phase 1
NCT03432741 Mar 2018 → Aug 2022 Hodgkins lymphoma , breast adenocarcinoma , mycosis fungoides , nodal marginal zone B-cell lymphoma Mayo Clinic
Terminated
No outcome recorded
Phase 1
NCT03128619 Aug 2017 → Mar 2022 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , invasive breast carcinoma , progesterone-receptor positive breast cancer Jonsson Comprehensive Cancer Center
Terminated
No outcome recorded
Phase 1
NCT03172884 Jun 2017 → Mar 2020 liver disorder Bayer
Completed
No outcome recorded
Phase 1
NCT02705859 Apr 2016 → May 2021 HER2 positive breast carcinoma Cancer Trials Ireland
Completed
No outcome recorded
Phase 1
NCT02253420 Oct 2014 → Mar 2018 —
Bayer
Completed
No outcome recorded
Phase 1
NCT02155582 Aug 2014 → Oct 2016 non-Hodgkin lymphoma Bayer
Completed
No outcome recorded
Phase 1
NCT02119221 Feb → Apr 2014 —
Bayer
Completed
No outcome recorded
Phase 1
NCT01460537 Nov 2011 → Jul 2015 neoplasm Bayer
Completed
No outcome recorded
Phase 1
NCT01411410 Aug 2011 → Oct 2014 neoplasm Bayer
Completed
No outcome recorded
Phase 1
NCT01404390 Aug 2011 → Mar 2012 neoplasm Bayer
Completed
No outcome recorded
Phase 1
NCT01392521 Jul 2011 → Feb 2014 neoplasm Bayer
Completed
No outcome recorded
Phase 1
NCT00962611 Nov 2009 → Feb 2016 neoplasm Bayer
Completed
No outcome recorded
Show 21 more trials Phase 1/2 16 trials
Phase 1/2
NCT05687721 Jun 2025 urothelial carcinoma VA Office of Research and Development
Withdrawn
No outcome recorded
Phase 1/2
NCT06218667 Jan 2024 → Jan 2027 prostate cancer Memorial Sloan Kettering Cancer Center
Withdrawn
No outcome recorded
Phase 1/2
NCT04939272 Jun 2022 → Feb 2027 expected mantle cell lymphoma City of Hope Medical Center
Active not recruiting
No outcome recorded
Phase 1/2
NCT04572763 Sep 2021 → Jul 2025 overdue diffuse large B-cell lymphoma Dana-Farber Cancer Institute
Active not recruiting
No outcome recorded
Phase 1/2
NCT04108858 May 2021 → Apr 2022 HER2 positive breast carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1/2
NCT04345913 Mar 2021 → Mar 2024 overdue female breast carcinoma , triple-negative breast carcinoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT04317105 Jul 2020 → Oct 2025 overdue metastatic malignant neoplasm National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 1/2
NCT04253262 Apr 2020 → Jan 2027 expected prostate carcinoma Brown University
Active not recruiting
No outcome recorded
Phase 1/2
NCT03877055 Mar 2019 → Oct 2022 mantle cell lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT03803761 Feb 2019 → Feb 2022 female breast carcinoma , invasive breast carcinoma , metastatic malignant neoplasm in the brain National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 1/2
NCT03711058 Jan 2019 → Jun 2022 colorectal cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
No outcome recorded
Phase 1/2
NCT03581942 Aug 2018 → Feb 2026 primary central nervous system lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT03458728 Apr 2018 → Feb 2023 Ewing sarcoma , neuroblastoma , osteosarcoma , rhabdomyosarcoma Bayer
Terminated
No outcome recorded
Phase 1/2
NCT03052933 Feb 2018 → Jul 2021 neoplasm of mature T-cells or NK-cells Chonnam National University Hospital
Completed
No outcome recorded
Phase 1/2
NCT02822482 Jun 2016 → Oct 2019 head and neck squamous cell carcinoma UNICANCER
Terminated
No outcome recorded
Phase 1/2
NCT02342665 Apr 2015 → Sep 2018 indolent B-cell non-Hodgkin lymphoma Bayer
Completed
No outcome recorded
Show 6 more trials Phase 2 21 trials
Phase 2
NCT05082025 Sep 2022 → May 2024 endometrial cancer , ovarian cancer M.D. Anderson Cancer Center
Terminated
No outcome recorded
Phase 2
NCT05295589 Jun 2022 → Mar 2023 fallopian tube endometrioid adenocarcinoma , fallopian tube serous adenocarcinoma , ovarian endometrioid adenocarcinoma , ovarian serous adenocarcinoma +1 National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 2
NCT04750941 Feb 2022 → Jun 2023 endometrial cancer , follicular lymphoma Columbia University
Terminated
No outcome recorded
Phase 2
NCT04685915 Feb 2021 → Mar 2023 B-cell chronic lymphocytic leukemia Inhye Ahn
Withdrawn
No outcome recorded
Phase 2
NCT05387616 Oct 2020 → Sep 2023 follicular lymphoma Ludwig-Maximilians - University of Munich
Unknown
No outcome recorded
Phase 2
NCT04433182 Aug 2020 → Dec 2024 diffuse large B-cell lymphoma Fondazione Italiana Linfomi - ETS
Terminated
No outcome recorded
Phase 2
NCT04263584 Jun 2020 → Apr 2025 diffuse large B-cell lymphoma University Hospital Muenster
Unknown
No outcome recorded
Phase 2
NCT04155840 Jan 2020 → Mar 2021 chronic lymphocytic leukemia/small lymphocytic lymphoma University of Washington
Terminated
No outcome recorded
Phase 2
NCT03474744 Dec 2019 → Dec 2027 expected marginal zone lymphoma Christian Buske
Active not recruiting
No outcome recorded
Phase 2
NCT03484819 Dec 2019 → Nov 2022 primary mediastinal large B-cell lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT03789240 Aug 2019 → Sep 2025 overdue follicular lymphoma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT06400238 Oct 2018 → Jan 2023 overdue adult lymphoma , plasma cell myeloma , refractory malignant neoplasm National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT06360588 Oct 2018 → Jan 2023 overdue cancer National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT03377101 Aug 2018 Her2-receptor negative breast cancer , estrogen-receptor positive breast cancer , progesterone-receptor positive breast cancer National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 2
NCT05490771 Jun 2018 → Jan 2021 overdue adult lymphoma , plasma cell myeloma National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02728258 Sep 2016 → Aug 2018 endometrial endometrioid adenocarcinoma , endometrial mixed adenocarcinoma , endometrial serous adenocarcinoma , endometrial undifferentiated carcinoma NRG Oncology
Completed
No outcome recorded
Phase 2
NCT02631590 Jul 2016 → Oct 2019 cholangiocarcinoma , gallbladder carcinoma H. Lee Moffitt Cancer Center and Research Institute
Completed
No outcome recorded
Phase 2
NCT02455297 Aug 2015 → Apr 2016 mantle cell lymphoma Bayer
Terminated
No outcome recorded
Phase 2
NCT02465060 Aug 2015 → Dec 2026 expected breast carcinoma , carcinoma of esophagus , cervical carcinoma , colon carcinoma +17 National Cancer Institute (NCI)
Active not recruiting
No outcome recorded
Phase 2
NCT02391116 May 2015 → Jul 2016 diffuse large B-cell lymphoma Bayer
Completed
No outcome recorded
Phase 2
NCT01660451 Nov 2012 → Jun 2016 non-Hodgkin lymphoma Bayer
Completed
No outcome recorded
Show 11 more trials Phase 3 3 trials
Phase 3
NCT02626455 Jan 2016 → Sep 2023 non-Hodgkin lymphoma Bayer
Terminated
No outcome recorded
Phase 3
NCT02369016 Sep 2015 → Oct 2022 non-Hodgkin lymphoma Bayer
Completed
No outcome recorded
Phase 3
NCT02367040 Aug 2015 → Aug 2020 non-Hodgkin lymphoma Bayer
Completed
No outcome recorded
Phase not stated 1 trial
— NCT06238583 — cancer Bayer
No longer available
No outcome recorded